Telehealth Platforms Stall on Enterprise Metrics as AI Monitoring Takes Share

No Major Telehealth Platform Announcements in Past Week

No telehealth platform vendor released verifiable enterprise data between March 2-9, 2026. Announcements from Teladoc Health, Caregility, and Talkiatry cited in recent roundups predate this window, originating in late February or early March without confirmed timing. Healthcare IT buyers evaluating 2026 budgets face a continued absence of concrete benchmarks, pricing updates, or adoption metrics from established virtual care platforms.

This silence contrasts with remote patient monitoring vendors, which project $3 billion in revenue by year-end 2026. AI-enhanced monitoring platforms now compete directly with pure-play telehealth for hospital budgets, particularly in hospital-at-home programs where staffing costs and readmission risks create measurable ROI.

Existing Platforms Add Features Without Quantified Impact

Teladoc Health expanded its 24/7 Care service for non-emergency virtual visits, positioning against Included Health's AI-powered care navigation. The update maintains Teladoc's scale advantage but discloses no pricing changes, customer counts, or cost-per-encounter data. Enterprise buyers see incremental improvement rather than a forcing event for contract renegotiation.

Caregility released an AI-enhanced iCare Coordinator that uses edge-based computer vision to monitor multiple hospital rooms simultaneously. The system targets staffing efficiency in hybrid care models, where nurse-to-patient ratios strain budgets. Caregility provided no benchmarks for time savings, error reduction, or deployment costs. Without baseline data, IT leaders cannot model ROI against existing nurse call systems or manual rounding protocols.

Talkiatry closed a $210 million Series D in February to expand virtual psychiatry for employer-sponsored plans. The funding pressures integrated platforms like Teladoc's behavioral health division to match network depth, but Talkiatry disclosed no enterprise adoption figures or per-member-per-month pricing. Behavioral health represents 30-40% of telehealth volume for large employers, making this a budget-sensitive category, yet buyers lack comparative cost data.

Remote Monitoring Platforms Gain Budget at Telehealth's Expense

Remote patient monitoring platforms now claim $3 billion in projected 2026 revenue, driven by hospital-at-home programs and chronic disease management. These systems combine continuous vitals tracking with AI-flagged interventions, reducing readmissions and ED visits with measurable outcomes. A hospital-at-home program using RPM typically reports 20-30% lower costs than inpatient care for eligible conditions, creating a direct budget justification absent from virtual visit platforms.

This shift reallocates IT and clinical budgets. A health system evaluating telehealth renewals must now compare per-visit costs against RPM's per-patient-per-month model, where continuous monitoring replaces episodic virtual consultations. Platforms without RPM integration risk losing share to hybrid vendors that bundle both capabilities.

What Enterprise Buyers Should Watch

Monitor HIMSS26 announcements for Q1 pilot data. Vendors including eClinicalWorks previewed AI API integrations at the conference, but adoption timelines and pricing remain unconfirmed. Early pilots may surface cost benchmarks by mid-Q2.

Demand RPM integration roadmaps from telehealth vendors during contract renewals. Pure virtual visit platforms face margin pressure as RPM captures chronic care budgets. Vendors without monitoring capabilities will need acquisition or partnership strategies by year-end.

Request comparative data on AI-assisted triage accuracy and cost-per-resolution. Teladoc and Included Health both cite AI-powered care navigation, but neither has published error rates, escalation percentages, or savings per member. Without this data, AI features remain marketing claims rather than decision criteria.

Expect pricing pressure in behavioral health. Talkiatry's $210 million raise signals investor confidence in virtual psychiatry, likely forcing incumbents to defend pricing or expand network capacity. Track wait times and per-session costs across vendors as a proxy for competitive intensity.